KDM1A and leukemia: Concomitant LSD1i - rapamycin treatment showed no synergistic effect, suggesting that mTOR inhibition is not sufficient to sensitize leukemia cells to LSD1 inhibition in vivo, although we cannot rule out suboptimal dosing despite usage of a relatively-high dosage45.